Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide Phase 3 trial in Japan
jRCT2080223329Phase 3Completed
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 3 trial of semaglutide. Started Sep 2016; status: completed.
02
Drugs
Beyond the preview
Go deeper on jRCT2080223329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223329.